Insider Trading History of Blackburn Brent K

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Blackburn Brent K since 2006. The trader's CIK number is 1238402. At the time of the last reporting, Blackburn Brent K was the SVP, Drug Discovery of Cv Therapeutics Inc. (stock ticker symbol CVTX). Also see all insider trading activities at Cv Therapeutics Inc.


Yearly summary of insider trading at Cv Therapeutics Inc (CVTX) by Blackburn Brent K

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2009 CVTX 0 $0 3,000 $37,320 226,457 $3,081,455
2008 CVTX 0 $0 43,894 $417,830 49,688 $360,281
2007 CVTX 0 $0 28,951 $284,440 37,732 $228,750
2006 CVTX 0 $0 0 $0 5,121 $0


Insider trading of Cv Therapeutics Inc (CVTX) by Blackburn Brent K

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2009-04-02 CVTX Option Ex 213,958 13.49 2,886,721
2009-02-25 CVTX Option Ex 12,499 15.58 194,734
2009-02-06 CVTX Sale 1,500 15.50 23,250
2009-01-07 CVTX Sale 1,500 9.38 14,070
2008-12-11 CVTX Option Ex 5,000 8.48 42,400
2008-12-09 CVTX Option Ex 5,000 9.51 47,550
2008-11-06 CVTX Sale 2,000 10.49 20,980
2008-10-14 CVTX Sale 2,000 8.93 17,860
2008-09-09 CVTX Sale 1,289 11.50 14,823
2008-08-13 CVTX Sale 1,500 10.17 15,255
2008-07-31 CVTX Option Ex 12,500 5.81 72,625
2008-07-31 CVTX Sale 12,500 9.50 118,750
2008-07-08 CVTX Sale 1,266 7.61 9,634
2008-06-17 CVTX Sale 839 7.93 6,653
2008-04-25 CVTX Option Ex 12,500 5.81 72,625
2008-04-25 CVTX Sale 12,500 9.51 118,875
2008-02-26 CVTX Option Ex 4,688 6.95 32,581
2008-01-10 CVTX Option Ex 10,000 9.25 92,500
2008-01-10 CVTX Sale 10,000 9.50 95,000
2007-12-11 CVTX Sale 18,951 9.69 183,540
2007-12-11 CVTX Option Ex 15,000 9.25 138,750
2007-08-16 CVTX Option Ex 10,000 9.00 90,000
2007-08-16 CVTX Sale 10,000 10.09 100,900
2007-01-03 CVTX Option Ex 12,732 .00 0
2006-12-05 CVTX Option Ex 5,000 .00 0
2006-01-03 CVTX Option Ex 121 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Blackburn Brent K (SVP, Drug Discovery of Cv Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.